Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
European Medicines Agency accepts submission of GSK's Marketing Authorisation Application for Zejula (niraparib) in first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer 2020-02-27 17:00
Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect 2020-02-27 15:49
WuXi Diagnostics' integrated testing solution for COVID-19 epidemiological investigation and diagnosis 2020-02-27 15:47
Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia 2020-02-27 08:00
Global Pharmaceutical Contract Manufacturing Organization Market to Reach $102.14 Billion by 2024 2020-02-27 01:28
KAHR Medical Raises $18 Million in Private Funding Round 2020-02-26 08:30
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19 2020-02-25 21:30
Connect Biopharma Enhances its Intellectual Property Estate for CBP-307, a Targeted Therapy with Potential in Multiple Autoimmune Diseases, with Patent Issuances in the United States, EU, Japan and Australia 2020-02-25 21:00
InDex Pharmaceuticals Publishes Mechanism of Action Data for Cobitolimod in Scientific Journal 2020-02-25 15:26
U.S. FDA accepts GSK's sNDA application for Zejula (niraparib) for first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer 2020-02-24 22:00
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Trial of APG-1387 in Combination with Chemotherapy for the Treatment of Advanced Pancreatic Cancer in China 2020-02-24 22:00
WuXi Biologics Congratulates Immutep on Positive Interim Data for IMP-321 2020-02-24 08:00
Nearly VND 20 billion sponsored by Vingroup for research projects on response to novel coronavirus 2020-02-21 10:09
VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update 2020-02-21 05:10
StoneWise AI-driven Drug Discovery Platform: Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment 2020-02-20 20:04
Sihuan Pharmaceutical Announces Acquisition of All Interests and Intellectual Property Rights of Plazomicin, A New Generation of Aminoglycoside Antibiotics in the Greater China Region 2020-02-20 18:59
111 Partners with Financial Institutions in Battle Against Coronavirus 2020-02-20 17:00
NeuroVive Pharmaceutical AB Year End Report January - December 2019 2020-02-19 16:08
VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update 2020-02-19 05:10
Volition Unveils Its Epigenetic Toolbox 2020-02-18 21:30
1 304 305 306 307 308 412